Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., Nov. 6, 2025 /PRNewswire/ -- CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous...
Hence then, the article about using skin biopsy technology cnd life sciences performs the 50 000th syn one test for patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test® for Patients )
Also on site :
- We Asked 4 Psychologists the Best Phrase To Use With Adult Children To Transform Your Relationship—They All Said the Same Thing
- Trump celebrates 80th birthday with a UFC fight at the White House as Americans pay the price for his Iran war
- Republican attorneys general urge EPA to classify mifepristone as water contaminant